STAMPEDE Will 'Change Practice' in High-Risk Prostate Cancer - Medpage Today

STAMPEDE Will 'Change Practice' in High-Risk Prostate Cancer - Medpage TodayПодробнее

Surveillance of Low-Risk Prostate Cancer Tripled - Medpage TodayПодробнее

Impact Slides: Practice-Changing Prostate Cancer StudyПодробнее

Do We Need USPSTF 'Encyclicals'? - Medpage TodayПодробнее

Is PSA Testing Flawed, Or Is the Trial Design? - Medpage TodayПодробнее

ASTRO: Lower PSA Relapse Risk Seen in Prostate Cancer StatinПодробнее

ASTRO: Radiation Cuts Mortality in Advanced Prostate CancerПодробнее

STAMPEDE: Abiraterone results (Short version)Подробнее

STAMPEDE Will 'Change Practice' in High-Risk Prostate Cancer - Medpage TodayПодробнее

#ESMO21 Highlights on MFS analysis from comb. treatments in high-risk adv. prostate cancer: STAMPEDEПодробнее

ASTRO: Proton Radiation Fails to Impress in Prostate CancerПодробнее

Staging Intermediate- and High-risk Prostate Cancer With 18F PSMA/PET/CT vs MRI #cancer #newsПодробнее

Another Win in Nonmetastatic CRPC - Medpage TodayПодробнее

ASTRO: Online Risk Calculator May Aid CounselingПодробнее

Opinion Makers: Revisiting the USPSTF Decision on PSA TestsПодробнее

ASCO GU: Some Object to Cancer Society's Prostate Screening UpdateПодробнее

Upfront Triplet Therapy Has OS Advantage in Men with mCSPC - Medpage TodayПодробнее

Defining Overdiagnosis in Cancer Screening - Medpage TodayПодробнее

High-risk Prostate Cancer ClinicПодробнее

Unmet needs for patients with prostate cancerПодробнее